Skip to content

VR simulation study of robot-assisted partial nephrectomy (RAPN)

A randomized controlled trial of the usefulness of VR simulation of robot-assisted partial nephrectomy (RAPN) for renal tumors

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1042220055
Enrollment
80
Registered
2022-08-17
Start date
2022-08-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumor renal tumor, renal cancer

Interventions

[VR group] 1) The DICOM image created from the preoperative contrast-enhanced CT is read into the medical imaging software Ziostation, and the radiological technologist (co-researcher Ohashi) builds a

Sponsors

Okada Atsushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with cT1 renal tumor (tumor diameter less than 70mm) considered suitable for RAPN surgery (2) Age between 20 and 80 on the date of obtaining consent (3) ECOG Performance Status (PS) is 0, 1 or less (4) Patients who have given informed consent in writing

Exclusion criteria

Exclusion criteria: (1) Patients for whom preoperative contrast-enhanced CT is difficult due to allergies or decreased renal function (2) In addition, patients who are judged to be inappropriate as research subjects by the research director (co-investigator)

Design outcomes

Primary

MeasureTime frame
Trifecta achievement rate ((1) Negative margins, (2) WIT within 25 minutes, (3) No perioperative complications)

Secondary

MeasureTime frame
Change in Cre, change in hemoglobin, change in CRP, change in urinary red blood cell count/white blood cell count Comparison of operation time, console time, console time, time from robot operation start to artery/tumor identification, and bleeding volume Trends in responses from surgeons using questionnaire items regarding the usefulness of VR

Contacts

Public ContactAtsushi Okada

Nagoya City University Graduate School of Medical Sciences

a-okada@med.nagoya-cu.ac.jp+81-52-853-8266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026